Ainos, Inc.
General ticker "AIMD" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $12.0M (TTM average)
Ainos, Inc. does not follow the US Stock Market performance with the rate: -10.2%.
Estimated limits based on current volatility of 4.1%: low 1.30$, high 1.41$
Factors to consider:
- Total employees count: 44 (-4.3%) as of 2024
- Top business risk factors: Capital access, Regulatory and compliance, Clinical trial success, Cybersecurity threats, Intellectual property risks
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.28$, 3.88$]
- 2026-12-31 to 2027-12-31 estimated range: [1.12$, 3.47$]
Financial Metrics affecting the AIMD estimates:
- Positive: with PPE of -0.5 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -57.13 <= 0.30
- Positive: 19.10 < Shareholder equity ratio, % of 36.23 <= 42.34
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Investing cash flow per share per price, % of -0.03 > -0.65
- Positive: Inventory ratio change, % of -94.84 <= -0.76
- Negative: negative Industry operating cash flow (median)
Short-term AIMD quotes
Long-term AIMD plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.12MM | $0.02MM | $0.12MM |
| Operating Expenses | $13.33MM | $13.86MM | $14.11MM |
| Operating Income | $-13.21MM | $-13.84MM | $-13.99MM |
| Non-Operating Income | $-0.56MM | $-1.02MM | $-0.78MM |
| Interest Expense | $0.14MM | $0.62MM | $0.71MM |
| R&D Expense | $7.32MM | $8.41MM | $7.75MM |
| Income(Loss) | $-13.77MM | $-14.86MM | $-14.77MM |
| Taxes | $0.00MM | $0.00MM | $0.00MM |
| Net Income(Loss)* | $-13.77MM | $-14.86MM | $-14.77MM |
| Stockholders Equity | $24.45MM | $15.52MM | $7.56MM |
| Inventory | $0.17MM | $0.14MM | $0.30MM |
| Assets | $31.84MM | $28.82MM | $20.87MM |
| Operating Cash Flow | $-4.69MM | $-5.81MM | $-4.61MM |
| Capital expenditure | $0.09MM | $0.02MM | $0.03MM |
| Investing Cash Flow | $-0.10MM | $-0.13MM | $-0.00MM |
| Financing Cash Flow | $4.92MM | $8.03MM | $1.01MM |
| Earnings Per Share** | $-3.36 | $-1.56 | $-3.46 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.